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From Nucleotides to Nuanced Law: The
Value of an Incremental Approach to
Experimentation in State-Level Genetic
Anti-Discrimination Legislation
Katelyn Fisher
16 U. MASS. L. REV. 311

ABSTRACT
A person’s genetic information tells a detailed story of what someone looks like,
who her relatives are, and even what illnesses she may develop. This information, as
enlightening as it may be, can be especially damaging when utilized in a
discriminatory way. This Note explores how the protections under the Genetic NonDiscrimination Act of 2008 will no longer be sufficient for protecting individuals
from genetic discrimination as the use of genetic information becomes more
commonplace. The questions become: Where do we start? How and where should
protections that extend to circumstances not covered by GINA be created in a way
that results in comprehensive protections against genetic discrimination? This Note
proposes that an effective way to achieve comprehensive protection is through
incremental change in genetic anti-discrimination law at the state level before
legislative change is attempted at the federal level. It argues that experimentation in
the laws at the state level will allow for thorough and meaningful protections by
allowing the concerns regarding genetic discrimination in the individual states to
catalyze their legislative responses and will allow the states to learn from other states
in determining effective paths for its own genetic non-discrimination legislation.
Finally, this Note will explore potential legal frameworks that states could use as a
model for genetic anti-discrimination legislation.
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I. INTRODUCTION
At the brink of the new millennium, the movie Gattaca hit
theaters.1 The film recounts the story of a young man shunned from
society and disqualified from lucrative employment because he was
not scientifically crafted to be the genetic highlight reel of his parents.2
Gattaca seemed like a science fiction exaggeration, a mere reflection
of what the world could become given the modern scientific
advancements in genetics.3 In actuality, Gattaca emulated what was
beginning to occur in the real world.4 Technological advancements,
like predictive medicine, have since propelled genetics to the scientific
forefront, making human genetic data readily available.5
A person’s genetic data has the potential to significantly advance
their medical treatment and biological self-understanding. However,
use of that data may extend beyond the intended medical setting and
into contexts where it may be used to her detriment.6 When genetic
data reveals that a person is predisposed to disease, that fact could be
honed into a tool of discrimination in the issuance of health insurance
policies, employment, mortgage lending, and education, as just a few
possibilities.7 With concerns regarding the use of medically acquired
genetic data in nonmedical contexts becoming more prevalent,
1
2
3
4

5
6

7

GATTACA (Columbia Pictures Industries 1997).
Id.
Id.
See Michael R. Dohn, Personal Genomics and Genetic Discrimination: Is
Increased Access a Good Thing?, 45 W. ST. L. REV. 107, 109–10 (2018)
(explaining the history behind the discriminatory use of genetic information).
“[The Eugenics] movement advocated for the sterilization of ‘undesirable’
individuals with the goal of improving the genetic composition of the population
as a whole.” Id. This occurred in the early twentieth century in over 30 states,
and “undesirable individuals” included those with physical or mental
disabilities. Id. at 110. These laws have since been repealed, but in the 1970’s
there was a rise in states requiring genetic tests for sickle cell anemia in African
Americans and following that were discriminatory practices against those who
possessed the gene. Id. at 110–11.
Id. at 112.
See id. at 112–13; see also Chadam v. Palo Alto Unified Sch. Dist., 666 Fed.
App’x 615, 615 (9th Cir. 2016) (detailing how a student was removed from
school due to the school’s belief that he had cystic fibrosis, when in actuality he
merely had the genetic marker for the disease).
See, e.g., Dohn, supra note 4, at 113 (describing the lack of limitations on the
use of genetic information in determinations related to health insurance policies
as a potential drawback).
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Congress enacted the Genetic Information Nondiscrimination Act
(“GINA”) in 2008.8 This Act created narrow protections for the use of
genetic data in employment practices and health insurance
determinations.9 GINA prevents both employers and health insurance
companies from purchasing, requesting, or requiring an individual’s
genetic information and from generally utilizing the information in a
discriminatory fashion.10
Though GINA provides limited protections against genetic
discrimination, it fails to protect against instances of genetic
discrimination in other industries.11 The potential use of genetic
information in forums outside of the employment and insurance arenas
is, as Gattaca demonstrated, astounding. Considering this, what is the
legal remedy for a child who is denied equal access to education based
on a genetic predisposition to a disease that has not physically
manifested?12 What protections are afforded to a person who is denied
a mortgage due to a genetic marker for a disease which may result in
premature death, but for which they are only mildly symptomatic?13
8
9

10
11

12

13

Genetic Information Nondiscrimination Act of 2008, 42 U.S.C. § 2000ff (2018).
See generally id. (setting forth the protections against genetic discrimination in
health insurance and employment).
Id. at § 101(d)(1)–(2).
See Anya E. R. Prince & Benjamin E. Berkman, When Does an Illness Begin:
Genetic Discrimination and Disease Manifestation, 40 J. L. MED. & ETHICS 655,
657–58 (2012) (arguing that GINA is both limited in scope and also fails to
define at what point a disease is considered physically manifested and therefore
no longer protected under GINA); see also Dohn, supra note 4, at 113
(highlighting the limited areas of GINA’s protection).
E.g., Chadam v. Palo Alto Unified Sch. Dist., 666 Fed. App’x 615, 615 (9th Cir.
2016). Though there was a remedy for this child under the ADA, the situation is
possibly predictive of other similar situations where protection under the ADA
may not be available. See Prince & Berkman, supra note 11, at 657 (under either
GINA or the ADA, “[t]here is arguably no protection for individuals who have
manifested some symptoms, but whose symptoms have not risen to the level of
substantial limitations”).
See Prince & Berkman, supra note 11, at 657–58. “GINA was structured such
that it only provides protection against misuse of genetic information up until
the point when an individual’s disease has manifested. It protects an individual
with a genetic predisposition for a disease, but not an individual actively
suffering from that disease.” Id. at 655. The point where a disease is considered
to have manifested for GINA protection purposes is not defined in GINA. Id.
This creates a gray area of situations where people may not be protected under
GINA, as “there will be a gap between when an asymptomatic individual will be
protected by GINA and when their symptoms will rise to the definition of
disability protected under the Americans with Disabilities Act (ADA).” Id. at
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GINA leaves such questions unanswered, and looking to the future, the
actions in response to these questions could become devastating
instances of discrimination based on genetics that do not currently
have an adequate legal remedy.14
As science evolves, laws governing genetic data must evolve
alongside it. Experimentation—in both science and legal policy—
values adaptation and learning from applied experience to build on
existing knowledge from past outcomes.15 This inherent need for
flexibility in the law lends itself well to legislation at the state level.16
As the availability and knowledge of genetic data evolves from its
relative legal infancy, the nature and extent to which genetic
discrimination will ultimately manifest is unknown.17 Legal reform at
the federal level requires some consensus among the states. Due to the
amount of time that will surely transpire before genetic discrimination
is recognized in areas beyond health insurance and employment, trying
to combat it at the federal level would be overly complex and
cumbersome.18 In 2008, the breadth of areas in which genetic
discrimination could arise was not concretely established, and if
specific contexts were considered they were not regarded as

14

15

16

17

18

657. A person is protected from discrimination based on a disability under the
ADA if they have “symptoms [that] substantially limit a major life activity.” Id.
See Dohn, supra note 4, at 126 (“[GINA] ‘does nothing to prohibit
discrimination in life insurance, disability insurance, long term care insurance,
or commercial transactions.’ The Act also does not address genetic
discrimination in the public education system or in housing.”).
Cf. James W. Fosset et al., Federalism & Bioethics: States and Moral Pluralism,
37 HASTINGS CTR. REP. 24, 25 (2007) (discussing the benefits of a federalist
approach to bioethics reform as “offer[ing] considerable advantages in
managing the political conflicts that inevitably arise from moral pluralism,
particularly around questions where there is no clear national consensus.”).
Id. States can manifest the ability to adapt to political and moral conflict and can
be strengthened through incremental legislative experimentation. See infra note
128.
See Jessica L. Roberts, Preempting Discrimination: Lessons from the Genetic
Information Nondiscrimination Act, 63 VAND. L. REV. 439, 481 (2010) (arguing
that basing legislation on fear of future harms is problematic, as “Congress is
incapable of anticipating how the discrimination will actually operate if it indeed
occurs”).
Cf. Fosset et al., supra note 15, at 28 (in the context of bioethics generally, states
can deal with interstate policy variations and “are able to take action on complex
and controversial bioethical issues if the federal government is unable to do
so”).
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sufficiently problematic to warrant protection.19 The states will vary in
their recognition of genetic discrimination as a pervasive issue in areas
GINA does not cover; and this disjunction of time and scope of
coverage makes a federal consensus unlikely.20
A state-by-state experimental approach offers a method of legal
advancement which reconciles the need for more comprehensive
genetic antidiscrimination legislation with the unpredictable nature of
the field to be regulated.21 States could enact laws tailored to local
discrimination issues that not only go beyond GINA’s limited
protections, but could also serve as a legislative blueprint for other
states to adopt as applicable.22 This represents an incremental
approach; relying on smaller, specific instances of experimentation at
the state level to respond to the prospective issues that genetic
discrimination presents, thereby advancing the progress of
comprehensive genetic antidiscrimination legislation.23
This Note will begin with the history of genetic research and how
science has led to the modern uses of genetic material. It will then
address the federal response to the increasing use and prevalence of
genetic information by passing GINA, and how the momentum of
scientific advancements has rendered GINA’s protections inadequate.
This Note proposes that protections beyond GINA must come in the
form of state-level legislation and focuses on the need for changes in
the state laws to be made in a deliberate, incremental fashion so states
have the freedom to experiment before the enactment of a
comprehensive federal law. The discussion then turns to the benefits of
using this approach to facilitate the legislative changes and will

19

20

21
22

23

Genetic Information Nondiscrimination Act of 2008 § 2(4)–(5), 42 U.S.C.
§ 2000ff (2018).
Cf. Fosset et al., supra note 15, at 25 (“state legislatures and courts have been
and continue to be major participants in the establishment and implementation
of bioethics policy”).
Id.
Cf. Robert A. Mikos, The Evolving Federal Response to State Marijuana
Reforms, 26 WIDENER L. REV. 1, 18 (2020) (when creating legislation, in the
context of federal marijuana regulation, it is “easier for a legislature to build
consensus behind a narrow, targeted measure” rather than “more comprehensive
reforms”).
See Charles E. Lindblom, The Science of “Muddling Through,” 19 PUB. ADMIN.
REV. 79, 85 (1959) (effective policy change can be made through a series of
minor changes that consecutively build upon the successes of previous policy).
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conclude with models the individual states could follow as they
develop genetic nondiscrimination legislation.
II. THE RISE OF THE UNDERSTANDING AND USE OF GENETIC
INFORMATION
While the complex mapping of the human genome was a
monumental accomplishment in science, it was also a slow and
painstaking process.24 Like most scientific discoveries, as the
understanding of the human genome deepened, so did its application.25
It is true that some of the uses of genetic information are relatively
benevolent, aimed at improving medical treatment with
recommendations based on the person’s unique genetics.26 The fear is
that this newfound accessibility of genetic data also invites invasions
of privacy and discrimination.27 Consequently, the federal government
enacted GINA, which prohibits discrimination based on genetics in
employment and health insurance settings.28 The continued scientific
advancements in this field will inherently result in genetic information
being more readily accessible than ever before, making GINA’s
limited protections ineffective.29
A. Brief History of Genetic Information
Through a scientific lens, a human’s “genetic information” is
relatively straightforward: it refers to the entirety of the human
genome. The genome is a sequence of millions of chemical building
blocks (DNA), constructed in a way that is unique to each individual,

24

25
26
27

28
29

See What is the Human Genome Project?, NAT’L HUM. GENOME RES. INST.,
https://www.genome.gov/human-genome-project/What
[https://perma.cc/FH4W-5NSN].
Id.
Id.
Genetic Information Nondiscrimination Act of 2008 § 2, 42 U.S.C. § 2000ff
(2018); see also Roberts, supra note 17, at 480–81 (discussing that the creation
of GINA was predicated on a fear of genetic discrimination in the workplace
and by health insurance companies).
See generally Genetic Information Nondiscrimination Act.
See Genetic Discrimination, NAT’L HUM. GENOME RES. INST.,
https://www.genome.gov/about-genomics/policy-issues/Genetic-Discrimination
[https://perma.cc/J7WS-VGEF] [hereinafter Genetic Discrimination].
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and controls all the physical characteristics of a particular person.30
The United States government started the Human Genome Project in
1990 for the purpose of identifying all human genes.31 Spanning nearly
fifteen years, the Project was completed in 2003 and disclosed the
sequence of nearly the entire human genome.32 Genetic information is
the foundation for every function in the human body, it determines
both basic attributes (hair or eye color) and the most complex of bodily
processes (protein creation).33 Apart from being indicative of a
person’s basic traits, genetic information can also be considered to
tailor medical treatment methods and predict health conditions.34 In a
sense, genes are a window into a person’s medical future because they
reveal predispositions to potential illnesses.35
As with any prediction, genes do not relay certainty, a person may
possess a gene signaling an increased risk for an illness or disease that
might never actually manifest.36 Thus, the use of a person’s genetic
data could lead to discrimination based on an illness she never actually
30

31

32

33

34

35
36

See generally A Brief Guide to Genomics, NAT’L HUM. GENOME RES. INST.,
https://www.genome.gov/about-genomics/fact-sheets/A-Brief-Guide-toGenomics [https://perma.cc/HSL8-7NQ4].
See AMANDA K. SARATA & JODY FEDER, CONG. RESEARCH SERV., RL34584,
THE GENETIC INFORMATION NONDISCRIMINATION ACT OF 2008 (GINA) 1 n.1
(2015).
Timeline of the Genetic Information Nondiscrimination Act (GINA), NAT’L
HUM. GENOME RES. INST., https://www.genome.gov/about-genomics/policyissues/timeline-genetic-information-nondiscrimination-act-GINA
[https://perma.cc/3W7V-39TV].
Phenotype, NAT’L HUM. GENOME RES. INST., https://www.genome.gov/geneticsglossary/Phenotype [https://perma.cc/2Z98-MML4] (explaining the different
characteristics controlled by genes); see also Dohn, supra note 4, at 112–13
(discussing how DNA collected in at-home testing kits can be used to discover
various characteristics about an individual).
See Bradley A. Areheart & Jessica L. Roberts, GINA, Big Data, and the Future
of Employee Privacy, 128 YALE L.J. 710, 719 (2019) (describing the most
important use of genetic information in science as being disease prediction);
Genetics vs. Genomics Facts Sheet, NAT’L HUM. GENOME RES. INST.,
https://www.genome.gov/about-genomics/fact-sheets/Genetics-vs-Genomics
[https://perma.cc/J8UM-CMZS] (explaining the use of genetic information in a
healthcare setting with an emphasis on understanding how genes interact with
the environment to cause disease).
Areheart & Roberts, supra note 34, at 719.
A Brief Guide to Genomics, supra note 30 (explaining that genetics play a role
in the manifestation of disease, but their manifestation may be subject to the
influence of environmental factors).
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experiences; and would have remained uncovered but for the scrutiny
of her genes.
B. Genetic Discrimination
The legal classification of genetic information is far more
complex than its scientific counterpart. From a legal standpoint,
genetic information encompasses an individual’s genetic tests, which
include any test that analyzes a person’s DNA to provide information
regarding the individual’s genetic sequence, genetic mutations, and
changes in their genome.37 It also includes the genetic data and
“manifestation of a disease or disorder” in that individual’s family
members.38
The broad scope of the legal definition of genetic information is
indicative of the problems presented by its unregulated use and
highlights the fields which require legal protection.39 The conclusions
that can be drawn about an individual from the genetic and health data
of their relatives creates an array of privacy concerns.40 Genetic
privacy concerns are heightened by the sensitive information it can
reveal about an individual. Genes can express not only predispositions
for illness and disease, but other traits that a person may desire to keep
private, such as stigmatized personality traits like addictive tendencies
and aggression.41 Considering that the genetic information from one
person could be indicative of their entire family’s genetic information,
it has the potential to trigger the discrimination of an entire group of
people.42
37

38
39

40
41

42

Genetic Information Nondiscrimination Act of 2008, § 201(4), (7), 42 U.S.C.
§ 2000ff (2018).
Id. at § 201(4)(A)(iii).
See Dohn, supra note 4, at 126–27 (identifying several categories that are
outside the scope of GINA where protection against genetic information
discrimination should be required).
Id.
See Jessica L. Roberts, The Genetic Information Nondiscrimination Act as an
Antidiscrimination Law, 86 NOTRE DAME L. REV. 597, 616–17 (2011)
(highlighting the collection of genetic information as a privacy concern based on
the availability of sensitive information); see also Andreas Meyer-Lindenberg et
al., Neural Mechanisms of Genetic Risk for Impulsivity and Violence in Humans,
103 PROC. OF THE NAT ACAD. OF SCI. 6269, 6272 (2006) (explaining the
complexities of correlating the prevalence of certain genes with increased levels
of aggression given the presence of other factors including environmental and
social).
Roberts, supra note 41, at 617.
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For those individuals with genetic predispositions that do manifest
and can be diagnosed, protections against discrimination may exist
under the Americans with Disabilities Act (“ADA”).43 The ADA
provides protections for people based on both physical and mental
disabilities.44 However, protections for genetic predispositions to
disease that do not manifest are not within the scope of the ADA.45
Protections for people with unmanifested-but-potential medical
issues identified through genetic sequencing were comparatively
absent before the enactment of GINA, as the pervasive potential of
genetic information usage was only beginning to arise.46 This
expansion of genetic information in the medical field highlighted a
new form of possible discrimination predicated on the mere possibility
of illness occurring.47 For instance, historically, health insurance
companies were not barred from considering a person’s genetic
predisposition for health conditions when deciding whether to issue a
policy.48 Health insurance providers were apt to raise prices to cover
illnesses a person was predisposed to or even deny issuing a policy
based on genetic markers and predispositions.49 It was the
vulnerability of individuals in cases like this that prompted the
enactment of GINA.50
C. The Enactment of GINA
In 2008 Congress noted a “current explosion in the science of
genetics,” which motivated them to enact GINA as a proactive
measure to combat genetic discrimination.51 The concerns over
43

44

45
46

47
48

49
50
51

See Prince & Berkman, supra note 11, at 657 (protection is dependent on
satisfying the definition of disability under the Act).
See id. (ADA is limited to protecting symptoms that substantially limit major
life activity).
Id.
See id. at 655 (GINA was enacted in response to technological advancements in
genetic science).
See id. at 655–56.
See Areheart & Roberts, supra note 34, at 722 (discussing the lack of protection
for genetic discrimination by health insurers before both GINA and the
Affordable Care Act).
Id.
Id. at 723–24.
Genetic Information Nondiscrimination Act of 2008, 42 U.S.C. § 2 (2018);
Roberts, supra note 41, at 625 (“GINA is a forward-looking statute—designed
to preempt a variety of discrimination before it becomes entrenched”).
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potential discriminatory uses of genetic information came on the tails
of the Human Genome Project being started.52 GINA was originally
introduced in Congress by Representative Louise Slaughter in 1995
and included protections against genetic discrimination in health
insurance, but the bill died before it could be voted on by Congress.53
The bill was reintroduced in 1999 with the additional protection
against genetic discrimination in employment but it failed to pass both
houses of Congress once again.54 The 1999 bill was reintroduced in
2002 by Senator Olympia Snowe.55 After two more unsuccessful
introductions, GINA was signed into law in 2008.56
The scope of GINA is highly limited, concerning only the “misuse
of genetic information in health insurance and employment.”57 In the
context of health insurance, GINA prohibits health insurance
companies from “request[ing], requir[ing], or purchas[ing] genetic
information for underwriting purposes.”58 In the area of employment,
employers cannot “request, require, or purchase genetic information
with respect to an employee or a family member of the employee.”59
Additionally, GINA generally proscribes an employer from
discriminating against an employee on the basis of their genetic
information.60
Outside of prohibiting employers and health insurers from
purposefully gathering genetic information and using that information
to explicitly discriminate against people, GINA leaves much to be
desired.61 Even the limited protections that are granted are subject to
exceptions and thus not entirely comprehensive.62 For example, GINA
does not provide recourse when health insurance companies

52
53

54
55
56
57

58
59
60
61
62

See SARATA & FEDER, supra note 31, at 3–4.
See Timeline of the Genetic Information Nondiscrimination Act (GINA), supra
note 32.
Id.
Id.
Id.
Genetic Information Nondiscrimination Act of 2008, § 2(1), 42 U.S.C. § 2000ff
(2018).
Id. § 101(d)(1).
Id. § 202(b).
Id. § 202(a).
Roberts, supra note 41, at 640.
See, e.g., Roberts, supra note 17, at 456–57.
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incidentally acquire a person’s genetic information.63 Apart from this
limited coverage, genetic-based discrimination remains unchecked and
unpunishable in other circumstances.
III. FEDERAL AND STATE ATTEMPTS TO ADDRESS THE SHORTFALLS
LEFT BY GINA
As expressed in the congressional findings of GINA, the science of
genetics is continually evolving which, in turn, expands the potential
use for genetic information.64 As a result, even though GINA was
meant to afford individuals protections against genetic discrimination
in the employment and health insurance fields it does nothing to
prevent genetic discrimination in other environments.65 For example, a
school in California was accused of removing a young male student
because he had a genetic marker that predisposed him to cystic
fibrosis.66 In that case, the school perceived the student as having a
disability because of his predisposition and removed him based on that
perception, which the court held was prohibited under the ADA.67 This
example of genetic discrimination in education showcases just one of
the venues not covered by GINA. But what would happen if the
genetic predisposition were for a characteristic that could not be
perceived as a disability under the ADA, like aggression?68 What
remedy is available for the person who is denied being considered as a
foster parent because they are predisposed to aggression? Given the
continuous advancements in technology and science, this is likely to
be just one of a myriad of instances of genetic discrimination not
currently prohibited by law.69
GINA is not a comprehensive statutory scheme and contains
several notable exceptions in the fields it does cover. In employment,
63
64
65
66

67
68

69

Id. at 456.
Genetic Information Nondiscrimination Act § 2.
See id.
Chadam v. Palo Alto Unified Sch. Dist., 666 Fed. App’x. 615, 616 (9th Cir.
2016).
Id.
See generally Meyer-Lindenberg et al., supra note 41, at 6272 (illustrating the
correlation between an individual’s genes and a predisposition for violent
behavior and aggression). Because the predisposition for aggression is not a
manifestation of a disability, it is unlikely to be covered by the ADA. See Prince
& Berkman, supra note 11, at 657.
See Dohn, supra note 4, at 128–29.
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GINA fails to prohibit the military from utilizing genetic information
of applicants in the hiring process.70 Nor does the Act extend to
employers with fewer than fifteen employees.71 As for health
insurance, GINA does not cover affiliate realms such as life insurance,
long-term care insurance, or disability insurance.72 As it stands, many
employers and the health insurance equivalents are not prohibited from
considering an individual’s genetic information.
Other federal laws minimally supplement the provisions of
GINA.73 The Health Insurance Portability and Accountability Act
(“HIPAA”) is a law that governs health-related information privacy.74
With the passage of GINA, HIPAA now includes genetic information
within the umbrella of health information, so it cannot be considered
by health insurance providers when determining plans and
premiums.75 GINA could also possibly be supplemented by the ADA,
which prohibits discrimination in several settings, including
employment and public accommodations.76 In 1995, the Equal
Employment Opportunity Commission (“EEOC”) interpreted the ADA
to cover “genetic information relat[ed] to illness, disease, or other
disorders.”77 Additionally, the EEOC considered that the ADA could
be applicable to preventing genetic discrimination in employment
settings.78 Finally, GINA is supplemented by the Affordable Care Act
of 2010 (“ACA”).79 The Act requires health insurance companies to
provide health insurance coverage to any person who requests it.80
Additionally, the ACA indirectly prohibits considering genetics when
determining the cost of coverage by excluding genetics from the
70
71
72
73
74
75

76
77
78

79
80

Genetic Discrimination, supra note 29.
Id.
Id.
Id.
Id.
Id. Unfortunately, HIPAA only protects the privacy of genetic information in
health insurance settings. Id.
Id.
Id.
Id. It is important to note that the interpretation by the EEOC does not legally
mandate a court to interpret the ADA as including genetic discrimination, and its
legal application is unknown as case law has not yet developed on the subject.
Id.
Id.
Id.
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narrow list of factors companies may use to vary the price of a
policy.81
Most states have adopted similar restrictions to those included in
GINA.82 However, some states go further and provide protections
against genetic discrimination in venues beyond GINA’s coverage.83
While this “small handful of states” have legislation governing the
disclosure of genetic information, they lack antidiscrimination
legislation specifically for genetic information.84 Yet the existence of
such legislation by the states clearly demonstrates their increasing
appreciation of the unique dangers attendant to the misuse of genetic
information.
As the legal concept of genetic discrimination remains nascent, the
states affording more protection against genetic discrimination than
GINA offer insight into the areas that some states recognize as
requiring additional protection. For example, California has enacted
the California Genetic Information Nondiscrimination Act
(“CalGINA”),85 which integrated the prohibition against genetic
discrimination into its civil rights law, making it unlawful to
discriminate against a person based on their genetics in all state-funded
business practices.86 This includes industries such as housing,
mortgage lending, and education.87 This approach to adopting laws
varying in degrees of protection, comparative to GINA, may result in a
patchwork of protections among the states, but it may also achieve a
comprehensive framework long before the federal law catches up.88
81

82

83
84

85

86
87

88

Id. (health insurers are permitted to change premiums based on limited factors
such as age and area of residence).
See generally Sally J.T. Necheles, Cause of Action for Violation of the Genetic
Information Nondiscrimination Act, 71 CAUSES OF ACTION 2D 537 § 73 (Supp.
2020) (illustrating the existing various state variations of GINA).
Dohn, supra note 4, at 124.
See id. (Alaska, Arizona, California, Florida, and Nevada, deal with genetic
information in the context of privacy rather than discrimination).
CalGINA, ch. 261, 2011 Cal. Stat. 2774 (codified in scattered sections of the
California Codes).
Id.
See Areheart & Roberts, supra note 34, at 725 n.58 (discussing the protections
against genetic discrimination afforded under CalGINA).
Cf. Summer Johnson, Editorial, Federalism, Federalism Everywhere, AM. J.
BIOETHICS, Nov. 2008, at 1–2 (in the context of state law governing human
research subjects, “[p]erhaps national consensus will emerge from the states”). It
follows that one possible outcome of state level experimentation in the law
governing genetic discrimination could result in a common understanding of the
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IV. INCREMENTALISM AS A PROPOSED SOLUTION
Considering the shortfalls within GINA and the ever-expanding
use of genetic information, legislative change is warranted. There are
two major benefits to starting this change at the state level. First, statelevel legislation is less daunting and can be enacted faster than federal
law. Second, incremental legislation allows for experimentation that
can result in a framework of laws which represent the specific needs of
the individual states to combat genetic discrimination.89
A. State-Level Experimentation to Effectuate the Creation of
Genetic Antidiscrimination Laws
An incremental approach to genetic antidiscrimination legislation
would both accurately reflect the needs of the several states in
providing protection to their citizens and catalyze change in the law
sooner than federally-enacted legislation.90 More specifically, this
state-level experimentation would foster both progressive awareness
and recognition of genetic discrimination as a growing cause for
concern.91 The focus on creating genetic anti-discrimination legislation
at the state level could avoid two issues that may arise if the law were
initially enacted at the federal level. First, making changes at the state
level could ameliorate the slow pace of federal legislation related to
genetic discrimination. Second, this approach could help close the
inevitable gaps that result from enacting federal legislation in a
developing area of law.92
Federal anti-discrimination statutes provide a uniform framework
that specifies precisely which areas of society lawmakers considered
merited protection. This uniformity would be particularly ineffective
for our purposes because the varying degrees to which states encounter
genetic discrimination would make it difficult to reach a consensus on

89

90
91
92

issue among the states. See Fosset et al., supra note 15, at 25 (highlighting how
these differences allow for experimentation resulting in better law).
Lindblom, supra note 23, at 85 (“small variations from present policy makes the
most of available knowledge”).
See Fosset et al., supra note 15, at 25.
See Lindblom, supra note 23, at 85.
JOHN V. SULLIVAN, HOW OUR LAWS ARE MADE, H.R. Doc. No. 110–49, at 1
(2007).
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what areas to protect.93 If the federal government decided to update
and expand current genetic antidiscrimination legislation, the process
would be laborious. In the time it would take for the bill to be
proposed, debated, and enacted, new areas of discrimination would
likely surface and be excluded from protection.94 This leaves the
federal legislature in a challenging position: attempt to pass a general
legislative ban on genetic discrimination or predict other industries
where protections against genetic discrimination may be warranted.
Both options could result in insufficient protections because the law, at
some point, must yield to the unpredictability of scientific
advancement.95
Implementing genetic antidiscrimination laws at the state level
would advance the understanding of circumstances that may require
protection, and provide each state the opportunity to craft specific laws
based upon what protections are necessitated.96 Individual states are
more familiar with the unique needs desires, and limitations of their
constituents because of their proximity to them.97 This connection
allows for genetic antidiscrimination laws governing different
instances of discrimination to be enacted more efficiently in the

93

94

95

96

97

Cf. Fosset et al., supra note 15, at 28 (discussing how states are better equipped
to handle a lack of national consensus in the field of bioethics due to a more
intimate understanding of local values and practicalities).
Cf. id. at 32 (in the context of stem cell research a “decentralized pattern of
policy development also provides a desirable means to develop national
answers”). In an area of law where there is unlikely to be national answers, the
will of the people regarding genetic discrimination legislation would be better
reflected if the law was changed at a level most intimate with the needs of the
citizens. Id. at 28.
Cf. id. at 27–28 (political “cross-pressures” on the national level can make
federal action impossible and therefore put states in a better position to pass
comprehensive legislation on important issues).
Cf. id. at 30 (“Allowing for variations in program structure and implementation
both permits the tailoring of program management to local conditions and
allows other states and the federal government to gain valuable information on
the most effective means of improving program performance.”); Kathryn L.
Tucker, Federalism in the Context of Assisted Dying: Time for the Laboratory to
Extend Beyond Oregon, to the Neighboring State of California, 41 WILLAMETTE
L. REV. 863, 879–80 (2005) (Oregon serving as a laboratory for the possibility
of physician-assisted dying).
Fosset et al., supra note 15, at 28.
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individual states.98 A state has the opportunity to act swiftly to propose
legislation prohibiting discrimination from continuing within the state,
which promotes a government that is “more immediately accountable
to individual[]” citizens of that state.99 If protections were enacted at
the federal level the long waiting periods would allow the
discrimination to perpetuate in unprotected areas, compounding the
injury to those subjected to the discrimination. Furthermore, fears over
the unregulated use of the genetic information could chill the
progression of genetic advancements.100
Enacting legislation at the state level could offer greater
protections to the citizens of individual states without violating their
rights under federal law. The Supremacy Clause of the United States
Constitution prevents states from reducing protections provided by
federal law.101 However, state laws that add protections to the floor
established by GINA would not conflict with federal law.102 With this
in mind, citizens would enjoy increased protections under both the
federal and state laws.103 This model will result in framework of
protective legislation that is more comprehensive in a wider breadth of
settings than GINA.104
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See Johnson, supra note 88, at 1 (arguing that in bioethics, states may enact
needed regulations if the federal government is failing to do so or is not doing it
fast enough).
Arthur C. D’Andrea, Note, Federalizing Bioethics, 83 TEX. L. REV. 1663, 1694
(2005); see also Tucker, supra note 96, at 879–80; Fosset et al., supra note 15,
at 30.
See Roberts, supra note 41, at 603–06 (GINA was passed as a way to mitigate
fears associated with unregulated use of genetic information and to encourage
participation in genetic testing to improve research and benefits to individuals);
see also Annet Wauters & Ine Van Hoyweghen, Global Trends on Fears and
Concerns of Genetic Discrimination: A Systematic Literature Review, 61 J.
HUM. GENETICS 275, 279–81 (2016) (discussing modern fears of genetic
discrimination of specific genes).
Preemption, CORNELL L. SCH.: LEGAL INFO. INST., https://www.law.cornell.edu
/wex/preemption [https://perma.cc/DC79-Z2EW]. This means any state law that
affords less protection than GINA directly conflicts with federal law and is
unenforceable. Id.
Id.
See, e.g., CalGINA, ch. 261, 2011 Cal. Stat. 2774 (codified in scattered sections
of the California Codes).
See id. CalGINA provides significant protections beyond the scope of GINA
while retaining GINA protections.
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There are likely endless ways in which genetic discrimination
could manifest as science in the field continues to develop. 105 States
and their respective legislatures and citizens, may differ in their
perspective of which rising issues should be a priority for legislative
action.106 The law in this sense is analogous to the human genome:
variation leads to evolution.107 The power of a state to enact genetic
anti-discrimination legislation is within the state’s general “police
power,” which allows the state to create regulations controlling the
welfare of its citizens so long as the law does not conflict with
established federal laws.108
Consider the implications of the following example. State A is
experiencing a significant issue with the usage of genetic information
for prejudicial purposes by its banks, which are considering the genetic
data of applicants when deciding whether to issue a loan or rejecting
loans for those who have the genetic marker for a disease.109 Under
this Note’s proposed model, State A may identify the discriminatory
conduct, and propose and enact legislation that would prevent it from
continuing in that setting. Subsequently, if State B is experiencing the
same issue, it may either implement legislation using State A as a
blueprint, or it could enact its own unique legislation. States where
citizens are experiencing genetic discrimination more pervasively can
serve as models for how such discrimination is handled so other states
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108
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See Fosset et al., supra note 15, at 29 (“[A]n active role for states in developing
and implementing bioethical policy provides for experimentation in the design
and implementation of complex bioethical decisions.”).
See id. at 28 (“Federalism tolerates great diversity in domestic policy . . . .”).
Tucker, supra note 96, at 879 (Experimentation in bioethics law in the context
of assisted dying “is exactly what Justice Brandeis contemplated in his famous
passage: ‘[i]t is one of the happy incidents of the federal system that a single
courageous state may, if its citizens choose, serve as a laboratory and try novel
social and economic experiments without risk to the rest of the country.’”
(quoting New State Ice Co. v. Liebermann, 285 U.S. 262, 311 (1932) (Brandeis,
J., dissenting))).
Police Power, BRITANNICA, https://www.britannica.com/topic/police-power
[https://perma.cc/D875-8DYY].
See generally Kaitlyn Dowling, Genetic Discrimination in Housing and
Lending: What’s the Risk?, PETRIE -FLOM CTR.: BILL OF HEALTH (Nov. 15,
2019), https://blog.petrieflom.law.harvard.edu/2019/11/15/genetic-discrimin
ation-in-housing-and-lending-whats-the-risk/ [https://perma.cc/CQ56-YLJH]
(providing information on the general concern regarding genetic discrimination
in housing and mortgage lending).
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could then emulate that approach.110 This allows the states to learn
from one another by analyzing both the pitfalls and successes of the
legislation of other states.111 With states serving as “laboratories of
democracy,” the passage of time allows states to contribute to the
collective understanding of genetic discrimination, resulting in
expansive genetic anti-discrimination laws.112
An incremental approach by states will hasten the acceptance of
genetic discrimination as a pervasive issue at the federal level. Passing
more effective legislation against genetic discrimination at the state
level should be effectuated to give states the opportunity to respond to
new forms of discrimination as they arise.113 While comprehensive
federal legislation remains the ultimate goal, it can be achieved more
easily once states have had time to appreciate the value of their
legislation and experiment with implementation strategies.114 The
present circumstances surrounding genetic antidiscrimination
legislation are well-suited for an incremental approach because there is
a lack of acceptance of its importance. This disparity in acceptance of
genetic discrimination as a tangible issue is demonstrated by the
majority of states not enacting any legislation to extend the limited
protections offered by GINA.115
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111

112
113

114

115

Tucker, supra note 96 at 864 (if a state chooses to enact a novel law it “would
do a service to the rest of the nation, as other states watch another state enact
and implement such a law”).
Id. at 880 (“It has been widely recognized that the states’ ability to experiment
with local solutions to public health problems is especially critical to the
development of wise public health policy.”).
See id. at 879–80.
James E. Krier & Mark Brownstein, On Integrated Pollution Control, 22
ENVTL. L. 119, 126 (1992) (discussing how a comprehensive approach to
solving environmental problems can lead to unrealistic reforms that ignore the
“imperfections of the real world”). In the context of environmental policy, it is
understood “that everything is interconnected, we fall into the logical fallacy of
believing the only way to improve those interconnections is to deal with them all
at once.” Id. at 125.
Lindblom, supra note 23, at 81 (before legislators can enact laws based on
public preferences, there must be public discussion to ensure a majority
preference accurately reflects the will of the public).
See generally Genome Statute and Legislation Database, NAT’L HUM. GENOME
RES. INST., https://www.genome.gov/about-genomics/policy-issues/GenomeStatute-Legislation-Database [https://perma.cc/99Y6-SKTU] (listing current and
recently pending state level legislation that concerns genetic discrimination, of
which there are few).
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Just as the understanding of genetics took years to develop, a fully
comprehensive framework of the genetic antidiscrimination law will
not be immediately realized in “one fell regulatory swoop,” but rather
it will be gradual as the circumstances in which genetic discrimination
can occur come to fruition.116 The path to effective and robust
“[p]olicy does not move in leaps and bounds.”117 States are likely to
disagree on approaches to understanding and tackling problems that
new issues present.118 Because the states vary in the amount of
urgency they place on expanding GINA’s protections, it is important
to prioritize progress over flawless legislation, as “perfect must not
become the enemy of the good.”119
The expansion of regulation of genetic antidiscrimination
legislation at the state level will allow for legislatures to develop novel
policy change on a trial-and-error basis within the state.120 That state
can then assess the success of the approach and modify it as necessary
which could incline other states to adopt a similar law. Implementing
laws governing genetic discrimination this way will also allow states
to work through the inevitable limitations of human knowledge when
working with a scientific moving target.121 Gradual change to the law
allows states to focus on instances of genetic discrimination that are
recognized by both scientists and society, which maximizes the benefit
116

117
118

119
120
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J.B. Ruhl & James Salzman, Climate Change, Dead Zones, and Massive
Problems in the Administrative State: A Guide for Whittling Away, 98 CALIF. L.
REV. 59, 62 (2010) (quoting Massachusetts v. Envtl. Prot. Agency, 549 U.S.
497, 524 (2007)). In the context of environmental regulation, instead of making
drastic changes in regulation, environmental agencies “instead whittle away at
them over time, refining their preferred approach as circumstances change and
as they develop a more-nuanced understanding of how to best proceed.” Id.
Lindblom, supra note 23, at 84.
Id. at 85–86 (“[T]he incremental pattern of policy-making fits with the multiple
pressure pattern. For when decisions are only incremental−closely related to
known policies, it is easier for one group to anticipate the kind of moves another
might make and easier too for it to make correction for injury already
accomplished.”).
Krier & Brownstein, supra note 113, at 128.
Cf. Erwin Chemerinsky et al., Cooperative Federalism and Marijuana
Regulation, 62 UCLA L. REV. 74, 78 (2015) (in the context of marijuana,
“willing states [should be allowed] to experiment with novel regulatory
approaches while leaving the federal prohibition intact for the remaining
states”).
See Lindblom, supra note 23, at 85 (“given the limits on knowledge within
which policy-makers are confined, simplifying by limiting the focus to small
variations from present policy makes the most of available knowledge”).
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of present awareness without attempting to blindly predict future areas
of concern.122 After sufficient experimentation, the successes of the
state-level legislative efforts could be integrated into a series of model
laws that other states and the federal government could use when
engaging in genetic antidiscrimination reform.123 The incremental
approach thus prevents legislatures from prematurely enacting
legislation by first educating the legislators on new areas of the law
requiring massive policy reform.124 Although incremental change is
gradual, in the sense that it is comprised of minor and unassuming
steps, it has the potential to be a faster route to comprehensive genetic
discrimination protection than slow but major legislative alterations.125
Given the uncertainty surrounding the sectors of society that will
definitively require protection, this approach allows each state to
create legislation based on their citizens’ unique needs by evaluating
the state’s unique political and social opinions to pinpoint areas of
vulnerability.126 The various states developing their own
comprehensive genetic nondiscrimination law will result in a body of
legislation and public policies beneficial to all states.127 These policies
will also be instrumental in the furtherance of protective legislation for
states in the future. By having an array of legislators and policymakers
creating tailored solutions in areas of genetic discrimination law states
could render more effective legislation.
122
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Id.
See generally Deanna Barmakian, Uniform Laws and Model Acts, HARV. L.
SCH. LIBR. (Nov. 4, 2020), https://guides.library.harvard.edu/law/unifmodelacts
[https://perma.cc/F8FD-LBZ9] (illustrating the use of model laws as a basis of
state legislation that can be adopted in whole or in part by a state).
Lindblom, supra note 23, at 85 (“Non-incremental policy proposals are therefore
typically not only politically irrelevant but also unpredictable in their
consequences.”).
See Charles E. Lindblom, Still Muddling, Not Yet Through, 39 PUB. ADMIN.
REV. 517, 520 (1979) (in the context of political change, “[a] fast-moving
sequence of small changes can more speedily accomplish a drastic alteration . . .
than can an only infrequent major policy change”).
See Ryan B. Stoa, Marijuana Agriculture Law: Regulation at the Root of an
Industry, 69 FLA. L. REV. 297, 362–63 (2017) (discussing an incremental
approach in the regulation of marijuana farming).
See Michael S. Sparer et al., Inching Toward Incrementalism: Federalism,
Devolution, and Health Policy in the United States and the United Kingdom, 36
J. HEALTH POL., POL’Y & L. 33, 42 (2011) (“[F]ederalism also creates legislative
and regulatory ‘opportunity points’ that lead to a more expansive set of public
policies.”).
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B. Legal Models States Could Follow to Address Genetic
Antidiscrimination
Governments in other countries have adopted various methods for
creating legislation prohibiting genetic discrimination.128 Britain for
example, has a moratorium in place on the use of genetic information
in the context of insurance.129 A moratorium could be beneficial in the
area of genetic discrimination because it is a temporary measure, and
such impermanence allows for the moratorium to change as the
understanding of genetic discrimination expands.130 Nonetheless,
because it is not permanent, its use would still require the legislature to
develop a plan for more enduring legal protections for victims of
discrimination.131 Moratoriums could be implemented in areas
identified as genetic discrimination trouble spots while the problem is
still developing; which would avoid creating concrete legislation until
the breadth and scope of the issue is understood. Returning to the
example set forth earlier, consider a state that has identified insidious
genetic discrimination in mortgage lending.132 The state may issue a
moratorium prohibiting banks from using genetic information when
considering the eligibility of borrowers for a ten-year period. During
that time, lawmakers could develop a more complete understanding of
what specific protections need to be afforded which would result in
effective legislation tailored to protect against such discrimination.
Passage of such legislation would then render the need for the
moratorium obsolete.
A different approach is used in Albania, where genetic
nondiscrimination is understood as a fundamental human right, and is
directly addressed in Albanian human rights legislation.133 Though
“[b]roadly formulated” to afford expansive protection from genetic
discrimination, this approach is subject to the interpretation of the
128
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See M. Otlowski et al., Genetic Discrimination: International Perspectives, 13
ANN. REV. GENOMICS HUM. GENETICS 433, 443 (2012); see also Yann Joly et
al., Comparative Approaches to Genetic Discrimination: Chasing Shadows?, 33
TRENDS IN GENETICS 299, 299–300 (2017).
Joly et al., supra note 128, at 299 (describing the moratorium Britain has for the
use of genetic information in providing health insurance policies).
Id. at 300.
Moratorium, CORNELL L. SCH.: LEGAL INFO. INST., https://www.law.cornell.edu
/wex/moratorium [https://perma.cc/YQ5N-YQMN].
See supra text accompanying note 109.
See Joly et al., supra note 128, at 300.
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courts and “statutory exceptions.”134 Because genetic information is
amalgamated with other broadly defined issues of human rights found
in the legislation, its judicial interpretation is malleable. In one sense,
judicial interpretation of the legislation could shore up ambiguities
regarding when and how protection is afforded against genetic
discrimination. In another sense, this malleability could also result in
inadvertent lapses in justice if the legislation is not consistently
applied. While broad legislation could be subject to the same shortfalls
in GINA, the benefits of this approach are found in the nuances of
judicial interpretation and application, which could fill any gaps left in
situation-specific legislation on genetic discrimination.135 In any case,
this is a model better suited for the final stages of genetic
discrimination reform, which would occur after the substantive law
governing genetic discrimination among the states is solidified or the
uniform law is enacted at the federal level.
Finally, states could also use GINA as a template to adopt
categorical prohibitions against specific patterns of genetic
discrimination as they arise. Unlike the other options, this approach is
already in use in California.136 This could be a beneficial approach, as
it allows the state to tailor the genetic antidiscrimination law to its
specific needs.137 For example, bans on genetic discrimination in
education may exist in one state at a given time, while another state
prohibits such discrimination in money lending. Of these three
potential models for legislation that presented above, no single one can
be expected to fit each state’s needs perfectly. The states may vary in
the method of effectuating legislative protections against genetic
discrimination, but the methods should be appropriate for the pursuit
of steady progress toward extensive genetic antidiscrimination
legislation.
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Id.
See Eduardo Ferrer Mac-Gregor, What Do We Mean When We Talk About
Judicial Dialogue?: Reflections of a Judge of the Inter-American Court of
Human Rights, 30 HARV. HUM. RTS. J. 89, 90–91 (2017) (discussing how courts
adapt to changing legal circumstances impacting human rights by looking to
each other through a concept called “judicial dialogue”).
See generally CalGINA, ch. 261, 2011 Cal. Stat. 2774 (codified in scattered
sections of the California Codes) (illustrating an example of an already enacted
state level categorical ban on genetic discrimination in several contexts).
Joly et al., supra note 128, at 300 (this approach could be referred to as
“Sectoral prohibition”).
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V. CONCLUSION
The infancy of genetic discrimination awareness in areas other
than those afforded protection in GINA creates the perfect opportunity
to create legislation before insidious discrimination can occur. Such
legislation would propound the legislative intent of GINA, which was
to preempt discrimination based on genetics before the practice could
harm citizens.138 As science continues in its pursuit of understanding
the human genome, problems implicated by the use of that information
will persist. Over time, the understanding of the human genome will
become more robust. As a result, legislation that protects against its
misuse for discriminatory purposes should be equally comprehensive.
The creation of legislation at the state level would allow states to learn
from one another regarding the areas needing protections and how to
effectuate those protections. This goal for effective genetic
antidiscrimination law would be facilitated by making the changes in
an incremental fashion to allow the issue of genetic discrimination to
become clearer, thus preventing ineffective predictive federal
legislation and protecting the rights of citizens in an ever-evolving
modern society.
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See Genetic Information Nondiscrimination Act of 2008, 42 U.S.C. § 2000ff
(2018).

